All protocols
Cognitive / Nootropic

PE-22-28 Peptide Protocol & Dosing

Updated 2mo ago 5 min read 195+ helpful Calculator
Validity Score

Validity Score

16 Speculative
Evidence 21
Community 35
Completeness 71
Actionability 80
Coverage 80
Penalty -26

This score combines formal evidence, page completeness, calculator readiness, and community convergence.

What it is

PE-22-28 is a preclinical spadin-derived peptide that blocks TREK-1 potassium channels and shows antidepressant-like effects in animal models. Human trials are not available.

Evidence boundary

Preclinical / speculative. Do not present a human dosing schedule as established fact.

Trial evidence

No verified human trial found.

Preparation and measurement

Reconstitution: 10 mg vial + 2 mL BAC = 5 mg/mL.

Concentration matches.

Reference schedule

Reference schedule
PhaseDoseDraw / measureFrequencyWeekly total
Weeks 1–2 (titration)50 mcg1 U (0.01 mL)Daily during cycle350 mcg/week
Weeks 3–8 (target)100 mcg2 U (0.02 mL)Daily during cycle700 mcg/week
Weeks 9–12 (optional)150 mcg3 U (0.03 mL)Daily during cycle1.05 mg/week
Weeks 13–16 (optional)200 mcg4 U (0.04 mL)Daily during cycle1.4 mg/week

Weeks 1–2 (titration)

Dose
50 mcg
Draw / measure
1 U (0.01 mL)
Frequency
Daily during cycle
Weekly total
350 mcg/week

Weeks 3–8 (target)

Dose
100 mcg
Draw / measure
2 U (0.02 mL)
Frequency
Daily during cycle
Weekly total
700 mcg/week

Weeks 9–12 (optional)

Dose
150 mcg
Draw / measure
3 U (0.03 mL)
Frequency
Daily during cycle
Weekly total
1.05 mg/week

Weeks 13–16 (optional)

Dose
200 mcg
Draw / measure
4 U (0.04 mL)
Frequency
Daily during cycle
Weekly total
1.4 mg/week

Weekly totals apply only during the active phase.

Titration rules

  • Daily titration (subcutaneous):

  • Weeks 1–2 (titration): 50 mcg/day.

  • Weeks 3–8 (target): 100 mcg/day. Common research dose.

  • Weeks 9–12 (optional): 150 mcg/day.

  • Weeks 13–16 (optional): 200 mcg/day. Upper end of researched range.

  • TREK-1 mechanism in the source literature

  • Limited human data

Practical rules

  • Pair with established mental-health care if relevant.
  • Do not present the dose ladder as validated human guidance.
Was this protocol helpful?
Share via
Supply & lot verification Availability and batch-linked COA records for PE-22-28 Peptide Protocol & Dosing are tracked with the current supplier listings. View availability & COA →

Dosing Calculator

10 mg + 2 mL BAC · week 1 50 mcg
LIVE CALCULATIONvolume / concentration / draw
RP–CALC–01
DRAW AMOUNT1 units0.01 mL · U-100
Draw 1 units, equivalent to 0.01 milliliters.
Concentration5 mg/mL
Selected dose0.05 mg (50 mcg) = 1 units
Enter a desired amount in milligrams or micrograms.
05 Standard amounts
1–10 mg · 0.5 mg steps
06 Suggested doses Select a row
1 unit = 0.01 mL on a U-100 syringe. Values retain decimal precision; visual marks are not silently snapped.
07 cycle summary

Vials required for Cycle

Estimate how much material you need for a full cycle, including cycle length and the number of cycles you plan to run.

Cycle total —
Total required vials —
Total reconstitution —
Total BAC water —
08 projected levels

How the draws stack up

A first-order model of depot absorption and elimination, run on the draws and cadence above. Pick the half-life from whatever your own source documents — this page does not assume one per compound. A planning sketch — not a prediction for any compound or any individual.

Half-life

Modelled level across the cycle. Each spike is one draw.

Accumulation—steady state vs one draw
Peak-to-trough—inside one interval
Steady state—about 4 half-lives
Draws modelled—at this cadence
Vial yieldat the selected amount
Draws per vial—
Lasts—
Volume used—
Limiting factor—
Water matrixsame vial, same amount
WaterStrengthDraw
0.5 mL——
1 mL——
2 mL——
3 mL——
5 mL——

Research Protocols

Keep up to date with latest protocols, updates and offers

An occasional email when a new protocol lands or an existing one is revised. No more than once a month.